Current Ratio of Grace Therapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Grace Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Grace Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 971%, a 3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Grace Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 971% -30% -3% 30 Sep 2025
Q2 2025 801% -544% -40% 30 Jun 2025
Q1 2025 775% -741% -49% 31 Mar 2025
Q4 2024 811% -461% -36% 31 Dec 2024
Q3 2024 1001% -128% -11% 30 Sep 2024
Q2 2024 1345% +363% +37% 30 Jun 2024
Q1 2024 1517% +531% +54% 31 Mar 2024
Q4 2023 1272% +163% +15% 31 Dec 2023
Q3 2023 1129% -137% -11% 30 Sep 2023
Q2 2023 982% -344% -26% 30 Jun 2023
Q1 2023 985% -627% -39% 31 Mar 2023
Q4 2022 1108% -895% -45% 31 Dec 2022
Q3 2022 1266% -683% -35% 30 Sep 2022
Q2 2022 1325% -354% -21% 30 Jun 2022
Q1 2022 1612% +725% +82% 31 Mar 2022
Q4 2021 2003% +1609% +408% 31 Dec 2021
Q3 2021 1949% 30 Sep 2021
Q2 2021 1680% 30 Jun 2021
Q1 2021 887% 31 Mar 2021
Q4 2020 394% 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.